Literature DB >> 15232614

FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia.

Hana Raslova1, Emiko Komura, Jean Pierre Le Couédic, Frederic Larbret, Najet Debili, Jean Feunteun, Olivier Danos, Olivier Albagli, William Vainchenker, Rémi Favier.   

Abstract

Paris-Trousseau syndrome (PTS; also known as Jacobsen syndrome) is characterized by several congenital anomalies including a dysmegakaryopoiesis with two morphologically distinct populations of megakaryocytes (MKs). PTS patients harbor deletions on the long arm of chromosome 11, including the FLI1 gene, which encodes a transcription factor essential for megakaryopoiesis. We show here that lentivirus-mediated overexpression of FLI1 in patient CD34(+) cells restores the megakaryopoiesis in vitro, indicating that FLI1 hemizygous deletion contributes to the PTS hematopoietic defects. FISH analysis on pre-mRNA and single-cell RT-PCR revealed that FLI1 expression is mainly monoallelic in CD41(+)CD42(-) progenitors, while it is predominantly biallelic in the other stages of megakaryopoiesis. In PTS cells, the hemizygous deletion of FLI1 generates a subpopulation of CD41(+)CD42(-) cells completely lacking FLI1 transcription. We propose that the absence of FLI1 expression in these CD41(+)CD42(-) cells might prevent their differentiation, which could explain the segregation of the PTS MKs into two subpopulations: one normal and one composed of small immature MKs undergoing a massive lysis, presumably originating from either FLI1(+) or FLI1(-) CD41(+)CD42(-) cells, respectively. Thus, we point to the role of transient monoallelic expression of a gene essential for differentiation in the genesis of human haploinsufficiency-associated disease and suggest that such a mechanism may be involved in the pathogenesis of other congenital or acquired genetic diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15232614      PMCID: PMC437972          DOI: 10.1172/JCI21197

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells.

Authors:  M Athanasiou; G Mavrothalassitis; L Sun-Hoffman; D G Blair
Journal:  Leukemia       Date:  2000-03       Impact factor: 11.528

2.  Response of naïve and memory CD8+ T cells to antigen stimulation in vivo.

Authors:  H Veiga-Fernandes; U Walter; C Bourgeois; A McLean; B Rocha
Journal:  Nat Immunol       Date:  2000-07       Impact factor: 25.606

Review 3.  Molecular and transcriptional regulation of megakaryocyte differentiation.

Authors:  R A Shivdasani
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

4.  Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.

Authors:  Eileen M Shore; Jaimo Ahn; Suzanne Jan de Beur; Ming Li; Meiqi Xu; R J McKinlay Gardner; Michael A Zasloff; Michael P Whyte; Michael A Levine; Frederick S Kaplan
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

Review 5.  The role of genomic imprinting in human developmental disorders: lessons from Prader-Willi syndrome.

Authors:  M L Hanel; R Wevrick
Journal:  Clin Genet       Date:  2001-03       Impact factor: 4.438

6.  Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia.

Authors:  A Hart; F Melet; P Grossfeld; K Chien; C Jones; A Tunnacliffe; R Favier; A Bernstein
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

7.  Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor.

Authors:  D D Spyropoulos; P N Pharr; K R Lavenburg; P Jackers; T S Papas; M Ogawa; D K Watson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  Allele-specific expression patterns of interleukin-2 and Pax-5 revealed by a sensitive single-cell RT-PCR analysis.

Authors:  K L Rhoades; N Singh; I Simon; B Glidden; H Cedar; A Chess
Journal:  Curr Biol       Date:  2000-06-29       Impact factor: 10.834

9.  Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice.

Authors:  Hiroshi Kawada; Tatsuya Ito; Pamela N Pharr; Demetri D Spyropoulos; Dennis K Watson; Makio Ogawa
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

Review 10.  Mouse models in the study of the Ets family of transcription factors.

Authors:  F O Bartel; T Higuchi; D D Spyropoulos
Journal:  Oncogene       Date:  2000-12-18       Impact factor: 9.867

View more
  46 in total

Review 1.  Lonely in Paris: when one gene copy isn't enough.

Authors:  Ramesh A Shivdasani
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

2.  Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1.

Authors:  Omar Moussa; Amanda C LaRue; Romeo S Abangan; Christopher R Williams; Xian K Zhang; Masahiro Masuya; Yong Z Gong; Demetri D Spyropoulos; Makio Ogawa; Gary Gilkeson; Dennis K Watson
Journal:  Mol Cell Biol       Date:  2010-09-07       Impact factor: 4.272

3.  Severe Progressive Autism Associated with Two de novo Changes: A 2.6-Mb 2q31.1 Deletion and a Balanced t(14;21)(q21.1;p11.2) Translocation with Long-Range Epigenetic Silencing of LRFN5 Expression.

Authors:  D R H de Bruijn; A H A van Dijk; R Pfundt; A Hoischen; G F M Merkx; G A Gradek; H Lybæk; A Stray-Pedersen; H G Brunner; G Houge
Journal:  Mol Syndromol       Date:  2010-02-12

Review 4.  Megakaryocyte biology and related disorders.

Authors:  Liyan Pang; Mitchell J Weiss; Mortimer Poncz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

5.  A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis.

Authors:  Sarah Bradshaw; W Jim Zheng; Lam C Tsoi; Gary Gilkeson; Xian K Zhang
Journal:  Clin Immunol       Date:  2008-08-09       Impact factor: 3.969

Review 6.  Erythro-megakaryocytic transcription factors associated with hereditary anemia.

Authors:  John D Crispino; Mitchell J Weiss
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

7.  Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage.

Authors:  Elizabeth A Kruse; Stephen J Loughran; Tracey M Baldwin; Emma C Josefsson; Sarah Ellis; Dennis K Watson; Paquita Nurden; Donald Metcalf; Douglas J Hilton; Warren S Alexander; Benjamin T Kile
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-31       Impact factor: 11.205

8.  Singling out FLI1 in Paris-Trousseau syndrome.

Authors:  Hervé Falet
Journal:  Blood       Date:  2017-06-29       Impact factor: 22.113

9.  Tescalcin is an essential factor in megakaryocytic differentiation associated with Ets family gene expression.

Authors:  Konstantin Levay; Vladlen Z Slepak
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology.

Authors:  Karen K Vo; Danuta J Jarocha; Randolph B Lyde; Vincent Hayes; Christopher S Thom; Spencer K Sullivan; Deborah L French; Mortimer Poncz
Journal:  Blood       Date:  2017-04-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.